AzTrials
AzTrials

Chronic Kidney DiseasesNCT06173141

Effect of Intradialytic Continuous Versus Interval Aerobic Exercises on Functional Capacity in Patients With Chronic Renal Failure.

A study testing low- to moderate-continuous intensity cycling exercises:, moderate- to high-interval intensity cycling exercises and hemodialysis sessions only in people with Chronic Kidney Diseases, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Chronic kidney disease has emerged as one of the leading causes of mortality worldwide, and it is one of a small number of non-communicable diseases that have shown an increase in associated deaths over the past 2 decades. Read more about this study

Who is it for?
Ages 35 to 55 years
Conditions the study is for
Chronic Kidney Diseases
What is being tested?
low- to moderate-continuous intensity cycling exercises:, moderate- to high-interval intensity cycling exercises and hemodialysis sessions only
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
67 participants
Where
1 siteEgypt
Study dates
30 Apr 2022to 30 Apr 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 35 to 55 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Sixty-seven patients of both sexes
  • Age will range from 35-55 years old.
  • BMI will be from 25-34.5 Kg/m2.
  • All patients with stage 5 of CRF.
  • All patients are stable on dialysis for at least six months before the study.
  • Stable medical and clinical hemodynamic state.

Who cannot join

  • 1. Patients with hearing impairment or mental disorder. 2. Patients with unstable angina, uncontrolled cardiac arrhythmia, decompensated heart failure, persistent systolic blood pressure (BP) greater than 200 mmHg, persistent diastolic BP greater than 120 mmHg, acute pericarditis or myocarditis.
  • 3. Patients with auto-immune diseases. 4. Chronic inflammatory orthopedic disorders and rheumatoid arthritis. 5. Patients with history of neuromuscular disease (muscular dystrophy, myasthenia gravis, myopathy, multiple sclerosis and peripheral neuropathy).
  • 6. Patients with chronic obstructive lung disease, restrictive lung disease or chronic chest infection.
  • 7. Patients with BMI > 35Kg/m2.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of Physical Therapy - Cairo University

    Cairo, 11517

Other trials in Egypt

About this study

Official title: Effect of Intradialytic Continuous Versus Interval Aerobic Exercises on Functional Capacity Quality of Life and in Patients With Chronic Renal Failure.

Chronic kidney disease has emerged as one of the leading causes of mortality worldwide, and it is one of a small number of non-communicable diseases that have shown an increase in associated deaths over the past 2 decades. The high number of affected individuals and the significant adverse impact of chronic kidney disease should prompt enhanced efforts for better prevention and treatment.

Chronic kidney disease is a serious medical problem, as it is associated with high risks of complications which lead to poor quality of life and physical capacity.

Read the detailed description

Sixty-seven patients undergoing haemodialysis randomly be allocated into three groups, (A, B \& C). Group A (low- to moderate-continuous intensity cycling exercises, group B (moderate- to high-interval intensity cycling exercises), the exercises performed two sessions per week for two months and group (C)Twenty three patients received the hemodialysis sessions only.

Group A (low- to moderate-continuous intensity cycling exercises:

Twenty three patients performed aerobic exercise during dialysis using Pedal machine at low- to moderate continuous intensity rating from 11 to 13 on the Borg scale for 15-30 minutes.

warming up and cool down (approximately 10 minutes) in form of free active exercise of the lower extremities.

Group B (moderate- to high-interval intensity cycling exercises), Twenty one patients performed aerobic exercise during dialysis using Pedal machine at moderate-to-high interval intensity rating from 12 to 15 on the Borg scale for 15-30 minutes.

warming up and cool down (approximately 10 minutes) in form of free active exercise of the lower extremities.

Inclusion Criteria:

  1. Sixty seven patients of both sexes
  2. Age will range from 35-55 years old.
  3. BMI will be from 25-34.5 Kg/m2.
  4. All patients with stage 5 of CRF.
  5. All patients are stable on dialysis for at least six months before the study.
  6. Stable medical and clinical hemodynamic state.

Exclusion criteria:

  1. Patients with hearing impairment or mental disorder.
  2. Patients with unstable angina, uncontrolled cardiac arrhythmia, decompensated heart failure, persistent systolic blood pressure (BP) greater than 200 mmHg, persistent diastolic BP greater than 120 mmHg, acute pericarditis or myocarditis.
  3. Patients with auto-immune diseases.
  4. Chronic inflammatory orthopedic disorders and rheumatoid arthritis.
  5. Patients with history of neuromuscular disease (muscular dystrophy, myasthenia gravis, myopathy, multiple sclerosis and peripheral neuropathy).
  6. Patients with chronic obstructive lung disease, restrictive lung disease or chronic chest infection.
  7. Patients with BMI > 35Kg/m2.
Being tested
low- to moderate-continuous intensity cycling exercises:, moderate- to high-interval intensity cycling exercises, hemodialysis sessions only
Keywords
Intradialytic cycling exercise, function capacity, hemodialysis, quality of life.
Medical subject headings
Renal Insufficiency, Chronic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • low- to moderate-continuous intensity cycling exercises:Other

    Also called low- to moderate-continuous aerobic exercise

    aerobic exercise during dialysis using Pedal machine at low- to moderate continuous intensity rating from 11 to 13 on the Borg scale for 15-30 minutes.

    warming up and cool down (approximately 10 minutes) in form of free active exercise of the lower extremities

  • moderate- to high-interval intensity cycling exercisesOther

    aerobic exercise during dialysis using Pedal machine at moderate-to-high interval intensity rating from 12 to 15 on the Borg scale for 15-30 minutes.

    warming up and cool down (approximately 10 minutes) in form of free active exercise of the lower extremities

  • hemodialysis sessions onlyOther

    hemodialysis sessions only

Study groups in NCT06173141
Study groupRoleWhat they receive
Group A (low- to moderate-continuous intensity cycling exercises:Active comparatorPatients performed aerobic exercise during dialysis using Pedal machine at low- to moderate continuous intensity rating from 11 to 13 on the Borg scale for 15-30 minutes. warming up and cool down (approximately 10 minutes) in form of free active exercise of the lower extremities
Receives: Other: low- to moderate-continuous intensity cycling exercises:
Group B (moderate- to high-interval intensity cycling exercises),Active comparatorPatients performed aerobic exercise during dialysis using Pedal machine at moderate-to-high interval intensity rating from 12 to 15 on the Borg scale for 15-30 minutes. warming up and cool down (approximately 10 minutes) in form of free active exercise of the lower extremities
Receives: Other: moderate- to high-interval intensity cycling exercises
group (C)Sham comparatorreceived the hemodialysis sessions only.
Receives: Other: hemodialysis sessions only

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Kidney Disease Quality of Life Questionnaire -SF36(KDQoL-SF36)

    The KDQOL™-36 contains 5 subscales: The Physical Component Summary (PCS), Mental Component Summary (MCS), Burden of Kidney Disease (BKD), Symptoms and Problems of Kidney Disease (SPKD), and Effects of Kidney Disease (EKD). The first 2 subscales are a generic measure of HRQOL (and are identical to the SF-12), whereas the last 3 assess issues specific to patients with ESRD or earlier stages of chronic kidney disease.

    Measured: pre and post treatment after 2 months

Secondary outcomes (2)
  1. blood urea, serum creatinine

    Blood samples are drawn from the arterial side of the hemodialysis access immediately prior to hemodialysis. Blood sample must be drawn before dialysis is started to prevent this sample from reflecting any impact of dialysis. pre and post kitz blood samples were sent to benha university hospital laboratory for estimating blood urea and creatinine.

    Measured: pre and post treatment after 2 months

  2. 6-min walk distance

    6min walk test carried out before and after the intervention to determine patient physical functional capacity. According to the American Thoracic Society ,Guidelines for the Six-Minute Walk Test (ATS .2002).

    Measured: pre and post treatment after 2 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Dec 2023
  2. Study start30 Apr 2022
  3. Primary completion30 Oct 2022
  4. Study completion30 Apr 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Sixty-seven patients undergoing haemodialysis randomly be allocated into three groups, (A, B \& C). Group A (low- to moderate-continuous intensity cycling exercises, group B (moderate- to high-interval intensity cycling exercises), the exercises performed two sessions per week for two months and group (C) received the hemodialysis sessions only.
Masking
Single blind
Who is masked
Participant
Enrolment
67 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06173141
Sponsor's protocol ID
Chronic renal failure
Status last verified
May 2025
First submitted
7 Dec 2023
Last updated
21 May 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Pei G, Tang Y, Tan L, Tan J, Ge L, Qin W. Aerobic exercise in adults with chronic kidney disease (CKD): a meta-analysis. Int Urol Nephrol. 2019 Oct;51(10):1787-1795. doi: 10.1007/s11255-019-02234-x. Epub 2019 Jul 22.

    PubMed 31332699
  • Wulczyn KE, Zhao SH, Rhee EP, Kalim S, Shafi T. Trajectories of Uremic Symptom Severity and Kidney Function in Patients with Chronic Kidney Disease. Clin J Am Soc Nephrol. 2022 Apr;17(4):496-506. doi: 10.2215/CJN.13010921. Epub 2022 Mar 4.

    PubMed 35246460

Questions about this trial

What is this clinical trial studying?

A study testing low- to moderate-continuous intensity cycling exercises:, moderate- to high-interval intensity cycling exercises and hemodialysis sessions only in people with Chronic Kidney Diseases, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Kidney Disease Quality of Life Questionnaire -SF36(KDQoL-SF36) (time frame: pre and post treatment after 2 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06173141, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in